Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia
Régis Peffault de Latour(Hôpital Saint-Louis), Gèrard Socié(Hôpital Saint-Louis), Mohamad Mohty(Sorbonne Université), Marlène Pasquet(Centre Hospitalier Universitaire de Toulouse), Fiorenza Barraco(Hôpital Lyon Sud), Thierry Leblanc(Jet Propulsion Laboratory), Charlotte Jubert(Centre Hospitalier Universitaire de Bordeaux), Reza Tabrizi(Université de Bordeaux), Flore Sicre de Fontbrune(Assistance Publique – Hôpitaux de Paris), Ambroise Marçais(Hôpital Necker-Enfants Malades), Suzanne Tavitian(Institut universitaire du cancer de Toulouse Oncopole), Stéphanie Nguyen(Sorbonne Université), T. Lamy(Centre Hospitalier Universitaire de Rennes), J Cahn(Centre Hospitalier Universitaire de Grenoble), Jacques Olivier Bay(Centre Hospitalier Universitaire de Clermont-Ferrand), Thorsten Braun(Humboldt-Universität zu Berlin), Claire Galambrun(Hôpital de la Timone), Éric Deconinck(European Union)
Cited by 31
Related Papers
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859